Vigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%

Bulletin Express07-15

Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier disclosures dated 27 November 2025, 29 June 2026, 6 July 2026 and 15 July 2026.

Prior to the transaction, the company had 66.68 million H shares in issue. The addition of 100.22 million converted shares lifts the Hong Kong-listed share count to 166.90 million, representing a 150.31% increase.

Correspondingly, the domestic unlisted share base shrank from 100.92 million to 0.70 million, a 99.31% reduction. Total issued share capital remains unchanged at 167.60 million shares, reflecting a reclassification rather than fresh issuance.

The board confirmed that the conversion was duly authorised and complied with all applicable listing rules and statutory requirements, with all proceeds duly received and relevant filings completed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148163359?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148163359","market":"us","top_or_hot":-1,"title":"Vigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%","media":"Bulletin Express","content":"<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier disclosures dated 27 November 2025, 29 June 2026, 6 July 2026 and 15 July 2026.</p>\n<p>Prior to the transaction, the company had 66.68 million H shares in issue. The addition of 100.22 million converted shares lifts the Hong Kong-listed share count to 166.90 million, representing a 150.31% increase.</p>\n<p>Correspondingly, the domestic unlisted share base shrank from 100.92 million to 0.70 million, a 99.31% reduction. Total issued share capital remains unchanged at 167.60 million shares, reflecting a reclassification rather than fresh issuance.</p>\n<p>The board confirmed that the conversion was duly authorised and complied with all applicable listing rules and statutory requirements, with all proceeds duly received and relevant filings completed.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVigonvita Life Sciences Converts 100.22 Million Domestic Shares into H Shares, Increasing Hong Kong-Listed Float by 150%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-15 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier disclosures dated 27 November 2025, 29 June 2026, 6 July 2026 and 15 July 2026.</p>\n<p>Prior to the transaction, the company had 66.68 million H shares in issue. The addition of 100.22 million converted shares lifts the Hong Kong-listed share count to 166.90 million, representing a 150.31% increase.</p>\n<p>Correspondingly, the domestic unlisted share base shrank from 100.92 million to 0.70 million, a 99.31% reduction. Total issued share capital remains unchanged at 167.60 million shares, reflecting a reclassification rather than fresh issuance.</p>\n<p>The board confirmed that the conversion was duly authorised and complied with all applicable listing rules and statutory requirements, with all proceeds duly received and relevant filings completed.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02630","symbol_name":"旺山旺水-B","start_time":0,"source_url":"","article_id":"1148163359","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148163359","pubTimestamp":1784109928,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02630":"旺山旺水-B"},"translate_title":"Vigonvita Life Sciences 将 10022 万股内资股转换为 H 股，香港上市流通量增加 150%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02630":1},"content_text":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) announced that on 15 July 2026 it completed the conversion of 100.22 million domestic unlisted shares into H shares. The move follows earlier disclosures dated 27 November 2025, 29 June 2026, 6 July 2026 and 15 July 2026.\nPrior to the transaction, the company had 66.68 million H shares in issue. The addition of 100.22 million converted shares lifts the Hong Kong-listed share count to 166.90 million, representing a 150.31% increase.\nCorrespondingly, the domestic unlisted share base shrank from 100.92 million to 0.70 million, a 99.31% reduction. Total issued share capital remains unchanged at 167.60 million shares, reflecting a reclassification rather than fresh issuance.\nThe board confirmed that the conversion was duly authorised and complied with all applicable listing rules and statutory requirements, with all proceeds duly received and relevant filings completed.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148163359","isCrawlerRequest":true}